"Leukemia, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
Descriptor ID |
D007942
|
MeSH Number(s) |
C04.557.337.372 C04.619.531 E05.598.500.496.500
|
Concept/Terms |
Leukemia, Experimental- Leukemia, Experimental
- Leukemias, Experimental
- Leukemia Model, Animal
- Animal Leukemia Model
- Animal Leukemia Models
- Leukemia Models, Animal
- Experimental Leukemia
- Experimental Leukemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Experimental".
This graph shows the total number of publications written about "Leukemia, Experimental" by people in this website by year, and whether "Leukemia, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 2 | 0 | 2 |
1998 | 3 | 0 | 3 |
2000 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Experimental" by people in Profiles.
-
CirinnĂ M, Trotta R, Salomoni P, Kossev P, Wasik M, Perrotti D, Calabretta B. Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation. Blood. 2000 Dec 1; 96(12):3915-21.
-
Skorski T, Wlodarski P, Daheron L, Salomoni P, Nieborowska-Skorska M, Majewski M, Wasik M, Calabretta B. BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac. Proc Natl Acad Sci U S A. 1998 Sep 29; 95(20):11858-62.
-
Salomoni P, Wasik MA, Riedel RF, Reiss K, Choi JK, Skorski T, Calabretta B. Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant. J Exp Med. 1998 Jun 15; 187(12):1995-2007.
-
Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B, Calabretta B. The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. Blood. 1998 Jan 15; 91(2):406-18.
-
Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J. 1997 Oct 15; 16(20):6151-61.
-
Skorski T, Perrotti D, Nieborowska-Skorska M, Gryaznov S, Calabretta B. Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo. Proc Natl Acad Sci U S A. 1997 Apr 15; 94(8):3966-71.
-
de Fabritiis P, Calabretta B. Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise? Haematologica. 1995 Jul-Aug; 80(4):295-9.